KND has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
KND has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Kindred Healthcare's Enterprise Value is $821 Mil. Kindred Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2018 was $-148 Mil. Therefore, Kindred Healthcare's EV-to-EBIT ratio for today is -5.53.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Kindred Healthcare's Enterprise Value is $821 Mil. Kindred Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2018 was $-41 Mil. Therefore, Kindred Healthcare's EV-to-EBITDA ratio for today is -19.81.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Kindred Healthcare's Enterprise Value is $821 Mil. Kindred Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2018 was $6,006 Mil. Therefore, Kindred Healthcare's EV-to-Revenue ratio for today is 0.14.
The historical data trend for Kindred Healthcare's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindred Healthcare Annual Data | |||||||||||||||||||||
Trend | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | |||||||||||
Enterprise Value | Get a 7-Day Free Trial | 2,563.12 | 3,929.29 | 4,109.74 | 3,894.54 | 4,090.35 |
Kindred Healthcare Quarterly Data | ||||||||||||||||||||
Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | |
Enterprise Value | Get a 7-Day Free Trial | 4,075.21 | 4,334.44 | 3,923.94 | 4,090.35 | 4,195.71 |
For the Medical Care Facilities subindustry, Kindred Healthcare's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Kindred Healthcare's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Kindred Healthcare's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Kindred Healthcare's Enterprise Value for the fiscal year that ended in Dec. 2017 is calculated as
Enterprise Value (A: Dec. 2017 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 887.1038 | + | 0 | + | 3146.972 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 14.638 | + | 224.436 | - | 182.8 |
= | 4,090 |
Kindred Healthcare's Enterprise Value for the quarter that ended in Mar. 2018 is calculated as
Enterprise Value (Q: Mar. 2018 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 835.20468 | + | 0 | + | 3266.364 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 14.482 | + | 210.825 | - | 131.166 |
= | 4,196 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kindred Healthcare (NYSE:KND) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Kindred Healthcare's EV-to-EBIT for today is
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 821.350 | / | -148.412 | |
= | -5.53 |
Kindred Healthcare's current Enterprise Value is $821 Mil.
Kindred Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-148 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Kindred Healthcare's EV-to-EBITDA for today is:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA(TTM) |
= | 821.350 | / | -41.465 | |
= | -19.81 |
Kindred Healthcare's current Enterprise Value is $821 Mil.
Kindred Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-41 Mil.
3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.
Kindred Healthcare's EV-to-Revenue for today is:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 821.350 | / | 6006.234 | |
= | 0.14 |
Kindred Healthcare's current Enterprise Value is $821 Mil.
Kindred Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,006 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Kindred Healthcare's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Heyward R Donigan | director | 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451 |
Phyllis R Yale | director | |
Paul J Diaz | director | 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202 |
Joel Ackerman | director | COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817 |
Richard Goodman | director | PEPSICO, INC., 700 ANDERSON HILL ROAD, PURCHASE NY 10577 |
Christopher T Hjelm | director | C/O THE KROGER CO., 1014 VINE ST., CINCINNATI OH 45202 |
Stephen D Farber | officer: EVP & Chief Financial Officer | 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202 |
Jonathan David Blum | director | C/O YUM BRANDS INC, 1441 GARDINER LANE, LOUISVILLE KY 40213 |
Lynn T Simon | director | 4000 MERIDIAN BOULEVARD, FRANKLIN TN 37067 |
Fred J Kleisner | director | C/O MORGANS HOTEL GROUP CO., 475 TENTH AVENUE, NEW YORK NY 10018 |
Sharad Mansukani | director | C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723 |
Thomas P Cooper | director | PO BOX 3335, SANTA FE CA 92067 |
John H Short | director | 7733 FORSYTH BLVD.,, SUITE 2300, ST. LOUIS MO 63105 |
Edward L Kuntz | director, other: Chairman of the Board | |
Richard A Lechleiter | officer: Executive VP and CFO | PO BOX 32890, LOUISVILLE KY 40232-2890 |
From GuruFocus
By gurufocus • 08-18-2009
By gurufocus • 08-14-2009
By gurufocus • 08-13-2009
By GuruFocus Research GuruFocus Editor • 09-08-2009
By gurufocus 10qk • 02-23-2011
By gurufocus • 08-19-2009
By GuruFocus Research GuruFocus Editor • 09-21-2009
By GuruFocus Research GuruFocus Editor • 09-21-2009
By GuruFocus Research GuruFocus Editor • 09-18-2009
By GuruFocus Research GuruFocus Editor • 09-23-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.